Terms: = Uterine cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Treatment
43 results:
1. Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
Shim SH; Lee JY; Lee YY; Park JY; Lee YJ; Kim SI; Han GH; Yang EJ; Noh JJ; Yim GW; Son JH; Kim NK; Kim TH; Kong TW; Choi YJ; Cho A; Lim H; Jang EB; Cho HW; Suh DH
J Gynecol Oncol; 2024 Mar; 35(2):e66. PubMed ID: 38330382
[TBL] [Abstract] [Full Text] [Related]
2. The promise of combining cdk4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma.
Ray-Coquard I; Monk BJ; Lorusso D; Mahdi H; Upadhyay V; Graul R; Husain A; Mirza MR; Slomovitz B
Int J Gynecol Cancer; 2023 Dec; 33(12):1943-1949. PubMed ID: 37907262
[TBL] [Abstract] [Full Text] [Related]
3. The SGK3-Catalase antioxidant signaling axis drives cervical cancer growth and therapy resistance.
Wang M; Liu J; Liao X; Yi Y; Xue Y; Yang L; Cheng H; Liu P
Redox Biol; 2023 Nov; 67():102931. PubMed ID: 37866161
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma.
Bayçelebi D; Kefeli M; Yıldız L; Karagöz F
Pol J Pathol; 2022; 73(3):233-243. PubMed ID: 36734438
[TBL] [Abstract] [Full Text] [Related]
5. A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial cancer.
Konstantinopoulos PA; Lee EK; Xiong N; Krasner C; Campos S; Kolin DL; Liu JF; Horowitz N; Wright AA; Bouberhan S; Penson RT; Yeku O; Bowes B; Needham H; Hayes M; Sawyer H; Polak M; Shea M; Cheng SC; Castro C; Matulonis UA
J Clin Oncol; 2023 Jan; 41(3):599-608. PubMed ID: 36174113
[TBL] [Abstract] [Full Text] [Related]
6. The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis.
Zhang Q; Zhu H; Cui Z; Li Y; Zhuo J; Ye J; Zhang Z; Lian Z; Du Q; Zhao KN; Zhang L; Jiang P
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009008
[TBL] [Abstract] [Full Text] [Related]
7. Novel Therapeutics in the treatment of uterine Sarcoma.
Bose S; Schwartz GK; Ingham M
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():900-909. PubMed ID: 35714303
[TBL] [Abstract] [Full Text] [Related]
8. Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial cancer Cell Lines (Ishikawa, HEC-1A, KLE).
Chen HY; Cheng WP; Chiang YF; Hong YH; Ali M; Huang TC; Wang KL; Shieh TM; Chang HY; Hsia SM
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361036
[TBL] [Abstract] [Full Text] [Related]
9. Inhibiting TLR9 Signaling Stimulates Apoptosis and Cell Cycle Arrest, and Alleviates Angiogenic Property in Human Cervical cancer Cells.
Wang L; Zhang S; Cai H; Qi Q; Zhang C; Qi Z; Huang C
Endocr Metab Immune Disord Drug Targets; 2022; 22(5):510-517. PubMed ID: 34161216
[TBL] [Abstract] [Full Text] [Related]
10. Silencing of circular RNA_0000326 inhibits cervical cancer cell proliferation, migration and invasion by boosting microRNA-338-3p-dependent down-regulation of cdk4.
Wang Z; Ren C; Yang L; Zhang X; Liu J; Zhu Y; Jiang D
Aging (Albany NY); 2021 Mar; 13(6):9119-9134. PubMed ID: 33735107
[TBL] [Abstract] [Full Text] [Related]
11. Glycyrrhizin Mediates Downregulation of Notch Pathway Resulting in Initiation of Apoptosis and Disruption in the Cell Cycle Progression in Cervical cancer Cells.
Ahmad A; Tiwari RK; Saeed M; Ahmad I; Ansari IA
Nutr Cancer; 2022; 74(2):622-639. PubMed ID: 33691557
[TBL] [Abstract] [Full Text] [Related]
12. Garcinol inhibits the proliferation of endometrial cancer cells by inducing cell cycle arrest.
Zhang M; Lu Q; Hou H; Sun D; Chen M; Ning F; Wu P; Wei D; Duan Y; Pan Y; Lash GE
Oncol Rep; 2021 Feb; 45(2):630-640. PubMed ID: 33416149
[TBL] [Abstract] [Full Text] [Related]
13. Methoxyeugenol regulates the p53/p21 pathway and suppresses human endometrial cancer cell proliferation.
Costa BP; Nassr MT; Diz FM; Fernandes KHA; Antunes GL; Grun LK; Barbé-Tuana FM; Nunes FB; Branchini G; de Oliveira JR
J Ethnopharmacol; 2021 Mar; 267():113645. PubMed ID: 33271245
[TBL] [Abstract] [Full Text] [Related]
14. LncRNA ZFAS1, as a poor prognostic indicator, promotes cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma.
Sun Y; Gao X; Li P; Song L; Shi L
Per Med; 2021 Jan; 18(1):43-53. PubMed ID: 33151128
[No Abstract] [Full Text] [Related]
15. Organosulphur Compounds Induce Apoptosis and Cell Cycle Arrest in Cervical cancer Cells via Downregulation of HPV E6 and E7 Oncogenes.
Ansari IA; Ahmad A; Imran MA; Saeed M; Ahmad I
Anticancer Agents Med Chem; 2021; 21(3):393-405. PubMed ID: 32819236
[TBL] [Abstract] [Full Text] [Related]
16. Abemaciclib sensitizes HPV-negative cervical cancer to chemotherapy via specifically suppressing cdk4/6-Rb-E2F and mTOR pathways.
Liu Y; Zhao R; Fang S; Li Q; Jin Y; Liu B
Fundam Clin Pharmacol; 2021 Feb; 35(1):156-164. PubMed ID: 32446293
[TBL] [Abstract] [Full Text] [Related]
17. Successful pregnancy after complete resection of leiomyomatosis peritonealis disseminate without recurrence:a case report with next-generation sequencing analysis and literature review.
Bu H; Jin C; Fang Y; Ma Y; Wang X; Chen J; Chen L
World J Surg Oncol; 2020 May; 18(1):85. PubMed ID: 32359372
[TBL] [Abstract] [Full Text] [Related]
18. Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.
Xiong Y; Li T; Assani G; Ling H; Zhou Q; Zeng Y; Zhou F; Zhou Y
Biomed Pharmacother; 2019 Apr; 112():108602. PubMed ID: 30784916
[TBL] [Abstract] [Full Text] [Related]
19. Down-regulation of long non-coding RNA ANRIL inhibits the proliferation, migration and invasion of cervical cancer cells.
Zhang WY; Liu YJ; He Y; Chen P
Cancer Biomark; 2018; 23(2):243-253. PubMed ID: 30198868
[TBL] [Abstract] [Full Text] [Related]
20. LncRNA NEAT1 regulates cervical carcinoma proliferation and invasion by targeting AKT/PI3K.
Guo HM; Yang SH; Zhao SZ; Li L; Yan MT; Fan MC
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4090-4097. PubMed ID: 30024596
[TBL] [Abstract] [Full Text] [Related]
[Next]
